2020

Lin JL, Huang PH, Yeh HI, Li YH.

Acta Cardiol Sin. 2020 Sep;36(5):403-408. (IF=2.672)

Appropriate Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Atherosclerotic Cardiovascular Disease: Comparison of Recommendations from Different Guidelines or Consensus Around the World.